Stockreport

FDA approves AbbVie's Rinvoq to treat moderate-to-severe RA [MarketWatch]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF FDA approves AbbVie's Rinvoq to treat moderate-to-severe RA The U.S. Food and Drug Administration has approved AbbVie Inc's ABBV, +2.10% Rinvoq, a JAK kinase inhibito [Read more]